Running up huge on volume right now! Thoughts?
Researchers awarded funding to expand Akebia drug trial
UTHealth News says Researchers have received funding from the Department of Defense to expand the Phase II clinical trial of vadadustat, a drug being developed by Akebia that could help prevent acute respiratory distress syndrome in Covid-19 patients, at The University of Texas Health Science Center at Houston, UTHealth News’ Amy Laukka reports. The award was given through the DOD’s Peer Reviewed Medical Research Program as a COVID Clinical Trial Award, according to the report. Akebia recently completed its global Phase III clinical trial development for the treatment of anemia due to chronic kidney disease in patients on dialysis and not on dialysis.
DOD funding helps expand study of investigational drug to prevent ARDS in COVID https://www.eurekalert.org/pub_releases/2021-01/uoth-dfh011321.php
——
39th Annual J.P. Morgan Healthcare Conference
January 13, 2021 at 2:50 PM EST
Discussion about this post